Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Inclusion Criteria

• •Patient whose age is ≥ 18 years
• •Patient with histologically proven pancreatic adenocarcinoma (biopsy or resection specimen)
• •Non-metastatic (M0) on the PCR form
• •Patient who received chemotherapy or radio-chemotherapy first
• •MRI and CT scans performed before or at the beginning of neo-adjuvant (or induction) treatment, during treatment and/or at the end of neo-adjuvant treatment (but before excision surgery)
• •French-speaking patient